What is the maximum daily dose of Anamorelin?

Anamorelin (Anamorelin) is a new drug for the treatment of cancer cachexia, and its recommended dosage is basically consistent in clinical application around the world. According to the data, the standard dosage of anamorelin is 100 mg orally once daily. This dose has been verified in multiple overseas clinical studies as a standard dose that achieves a good balance between safety and efficacy, and is also the highest recommended dose approved by most national drug regulatory agencies.

There is currently no evidence to support the safety or necessity of dosages exceeding 100 mg daily. Since anamorelin increases appetite by stimulating gastrin receptors and may improve muscle synthesis, its pharmacological effects are well established at recommended doses. If the patient increases the dosage on his own, not only will the efficacy of the drug not be significantly enhanced, but it may increase the risk of adverse reactions, especially the occurrence of side effects such as arrhythmia, hyperglycemia, abdominal distension, or water retention. In special cases, if the patient takes other drugs that affect pharmacokinetics or has abnormal liver and kidney function, doctors may need to fine-tune the dose. However, such adjustments usually belong to individualized management and cannot be promoted as a routine strategy.

It should also be emphasized that the absorption and metabolism of anamorelin are highly dependent on liver enzymesCYP3A4. If patients also use CYP3A4 inhibitors such as ketoconazole, the blood concentration may increase, thereby aggravating side effects. Likewise, inducers such as carbamazepine may reduce drug efficacy. Therefore, drug interactions are also important factors influencing dosing decisions.

During the patient's daily medication, they should insist on taking it on an empty stomach at the same time every day to maximize the drug effect and maintain stable blood concentration. At the same time, it is recommended that patients closely observe changes in appetite, weight and functional status during the initial period of taking it, and conduct muscle mass assessment if necessary.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/